Asymchem Laboratories (002821.CH) 2021H1 Results - Not Good Enough
This article analyzed Asymchem in terms of its 2021/1H financial results, the comparison with peers, the concerns on growth, the valuation and the...
204 Views
Pre-IPO Ambio Pharmaceuticals - The Particularity of Peptide Drugs, the Strength and the Concerns
The article mainly analyzed Ambio Pharmaceuticals in terms of the particularity of peptide drugs & industry characteristics, the strength of its...
526 Views
Pre-IPO Asymchem Laboratories - The Strength and the Concerns
The article mainly analyzed Asymchem Laboratories in terms of the industry characteristics, the strength of its business, the comparison with...
275 Views
Pre-IPO Sinohealth Technology - Solid Financial Performance Cannot Cover up the Challenges Ahead
This article mainly analyzed Sinohealth in terms of the industry characteristics, its business, comparison with peers (Yidu Tech, Linkdoc, etc.),...
293 Views
China A-Shares - EM Fund Ownership Guide
China A-Shares represent the 6th largest country holding among active EM investors. In this analysis, we analyse the current set up of A-Shares in...
261 Views